Cytoplasmic
blebs in lymphocytes… a search of the internet didn’t really tell me (in words
of one syllable) what they are all about. They would seem to be a feature
of either leukaemic of apoptotic cells.
Either way
they aren’t good…
This is (supposed to be) a reflective diary by a (not very) anonymous biomedical scientist who works somewhere in the south of England. One day this diary may well be submitted to the Health and Care Professions Council as evidence of ongoing continual professional development....
17 December 2019 (Tuesday) - Haemostasis
The A.S.H.
sent an update on haemostasis today:
 |
Romiplostim Improves Platelet Counts, Chemotherapy Adherence in Patients With Chemotherapy-Induced Thrombocytopenia Patients with solid tumor cancers were able to continue treatment with chemotherapy with fewer delays and dose reductions, though efficacy was less robust in patients with lymphoid malignancies. |
 |
Registry Analysis Finds Off-Label Rituximab Improves Outcomes in Patients With iTTP In subgroup analyses, the authors also noted that Caucasian patients with relapsed iTTP had significantly longer relapse-free survival, compared with African American patients. |
 |
Romiplostim and Eltrombopag Beat Rituximab for Secondline Chronic Immune Thrombocytopenia Treatment The two FDA-approved thrombopoietin receptor agonists were associated with lower risks of complications for patients whose disease failed to respond to corticosteroids. |
16 December 2019 (Monday) - Christmas Disease
The nice
people at Lablogatory sent a case study today – Christmas
disease.
I’ve
mentioned before that I struggle to get haemostasis-related CPD…
Subscribe to:
Posts (Atom)